Human Papilloma Virus infection in individuals with oral cavity and oropharynx cancer treated at a tertiary hospital in Salvador, state of Bahia, Brazil
Uri Ramos Firmo, Ana Laura Santos Anjos, Thiago Pinto da Silva, Joice Neves Reis, Junia Raquel Dutra Ferreira
Abstract
Introduction: Oropharyngeal and oral cavity carcinoma (OOCC) ranks as the fifth most common cancer in men, in Brazil. Traditionally, OOCC has been linked with smoking and alcohol consumption in older individuals; however, the emergence of these cancers in younger individuals has been associated with Human Papillomavirus (HPV) infection. Despite this connection, there are currently no available data estimating the prevalence of this infection in our population. Objective: Investigate HPV infection in patients diagnosed with OOCC treated at a tertiary cancer-specialized hospital in Salvador, state of Bahia, Brazil. Methods: Retrospective, observational, descriptive study on patients diagnosed with OOCC at Hospital Aristides Maltez (HAM) from 2017 to 2020. Clinical and epidemiological data were collected from medical records and analyzed by the SPSS® 22.0 software considering a statistical significance level of 5% (p<0.05) . Results: Of the 39 individuals with OOCC, 43.6% were over 60 years old, and 79.5% were male. Ten individuals (25.6%) were HPV-positive due to p16 expression. These patients were older (63.0 ±10) compared with HPV-negative individuals (p=0.03). The older population was associated with more advanced conditions among HPV-negative patients (r=0.397; p=0.04). The prevalence of HPV infection among OOCC patients, based on p16 expression by immunohistochemistry assay, was 25.6%. The group with HPV-positive OOCC had a higher mean age. Conclusion: Most cases of OOCC in the studied population do not seem to be associated with HPV infection. The prevalence of HPV infection in our population indicates that public policies should focus on preventing alcohol and tobacco use, fostering immunization, and providing comprehensive sex education.
Keywords
References
1. Brasil. Ministério da Saúde. Instituto Nacional de Câncer. Estimativa de incidência e mortalidade por câncer no Brasil. Rio de Janeiro: Secretaria de Atenção à Saúde; 2020.
2. OMS. Cancer [Internet]. 2021 [cited 2021 Sept 19]. Available from: https://www.who.int/westernpacific/health-topics/cancer
3. Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Human Papilloma Virus in Gynaecology. 2018;47:14-26.
4. Gomes VMS, Saraiva WB, Silva PFN, Leite RA. Mortalidade brasileira por câncer de cavidade oral. Rev Soc Bras Clin Med. 2018;16(3):164-6.
5. Brasil. Ministério da Saúde. Instituto Nacional de Câncer. Estimativa de incidência e mortalidade por câncer no Brasil. Rio de Janeiro: Secretaria de Atenção à Saúde; 2020.
6. ACS. HPV and Cancer [Internet]. 2021 [cited 2021 Sept 19]. Available from: https://www.cancer.org/cancer/cancer-causes/infectious-agents/hpv/hpv-andcancer-info.html
7. Graham SV. Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies. Future Microbiol. 2010;5(10):1493-506. http://dx.doi.org/10.2217/fmb.10.107. PMid:21073310.
8. Demarco M, Hyun N, Carter-Pokras O, Raine-Bennett TR, Cheung L, Chen X, Hammer A, Campos N, Kinney W, Gage JC, Befano B, Perkins RB, He X, Dallal C, Chen J, Poitras N, Mayrand MH, Coutlee F, Burk RD, Lorey T, Castle PE, Wentzensen N, Schiffman M. A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs. EClinicalMedicine. 2020;22:100293. http://dx.doi.org/10.1016/j.eclinm.2020.100293. PMid:32510043.
9. De Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664-70. http://dx.doi.org/10.1002/ijc.30716. PMid:28369882.
10. Petito G, Carneiro MAS, Santos SHR, Silva AM, Alencar RC, Gontijo AP, Saddi VA. Human papillomavirus in oral cavity and oropharynx carcinomas in the central region of Brazil. Rev Bras Otorrinolaringol (Engl Ed). 2017;83(1):38-44. http://dx.doi.org/10.1016/j.bjorl.2016.01.004. PMid:27117892.
11. Castro TPPG, Bussoloti I Fo. Prevalence of human papillomavirus (HPV) in oral cavity and oropharynx. Rev Bras Otorrinolaringol (Engl Ed). 2006;72(2):272-82. http://dx.doi.org/10.1016/S1808-8694(15)30068-9. PMid:16951865.
12. Pytynia KB, Dahlstrom KR, Sturgis EM. Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol. 2014;50(5):380-6. http://dx.doi.org/10.1016/j. oraloncology.2013.12.019. PMid:24461628.
13. Panatto D, Amicizia D, Trucchi C, Casabona F, Lai PL, Bonanni P, Boccalini S, Bechini A, Tiscione E, Zotti CM, Coppola RC, Masia G, Meloni A, Castiglia P, Piana A, Gasparini R. Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies. BMC Public Health. 2012;12(1):623. http://dx.doi. org/10.1186/1471-2458-12-623. PMid:22871132.
14. Dunne EF, Park IU. HPV and HPV-associated diseases. Infect Dis Clin North Am. 2013;27(4):765-78. http://dx.doi.org/10.1016/j.idc.2013.09.001. PMid:24275269.
15. Castellsagué X, Alemany L, Quer M, Halec G, Quirós B, Tous S, Clavero O, Alòs L, Biegner T, Szafarowski T, Alejo M, Holzinger D, Cadena E, Claros E, Hall G, Laco J, Poljak M, Benevolo M, Kasamatsu E, Mehanna H, Ndiaye C, Guimerà N, Lloveras B, León X, Ruiz-Cabezas JC, Alvarado-Cabrero I, Kang CS, Oh JK, Garcia-Rojo M, Iljazovic E, Ajayi OF, Duarte F, Nessa A, Tinoco L, Duran-Padilla MA, Pirog EC, Viarheichyk H, Morales H, Costes V, Félix A, Germar MJ, Mena M, Ruacan A, Jain A, Mehrotra R, Goodman MT, Lombardi LE, Ferrera A, Malami S, Albanesi EI, Dabed P, Molina C, López-Revilla R, Mandys V, González ME, Velasco J, Bravo IG, Quint W, Pawlita M, Muñoz N, de Sanjosé S, Xavier Bosch F. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Inst. 2016;108(6):djv403. http://dx.doi.org/10.1093/jnci/djv403. PMid:26823521.
16. Tristão W, Ribeiro RM, Oliveira CA, Betiol JC, Bettini Jde S. Epidemiological study of HPV in oral mucosa through PCR. Rev Bras Otorrinolaringol (Engl Ed). 2012;78(4):66-70. PMid:22936139.
17. Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, Roberts S. The prevalence of human papillomavirus in oropharyngeal and non-oropharyngeal head and neck cancer: Systematic review and meta-analysis of trends by time and region. Head Neck. 2013;35(5):747-55. http://dx.doi.org/10.1002/hed.22015. PMid:22267298.
18. Mirghani H, Bellera C, Delaye J, Dolivet G, Fakhry N, Bozec A, Garrel R, Malard O, Jegoux F, Maingon P, Sarini J, Noel G, Duflo S, Temam S, Lefebvre JL, Costes-Martineau V. Prevalence and characteristics of HPV-driven oropharyngeal cancer in France. Cancer Epidemiol. 2019;61:89-94. http://dx.doi.org/10.1016/j. canep.2019.05.007. PMid:31158796.
19. Zamani M, Grønhøj C, Jensen DH, Carlander AF, Agander T, Kiss K, Olsen C, Baandrup L, Nielsen FC, Andersen E, Friborg J, von Buchwald C. The current epidemic of HPV-associated oropharyngeal cancer: an 18-year Danish population-based study with 2,169 patients. Eur J Cancer. 2020;134:52-9. http://dx.doi.org/10.1016/j.ejca.2020.04.027.
20. Valls-Ontañón A, Hernández-Losa J, Somoza Lopez de Haro R, Bellosillo-Paricio B, Ramón Y Cajal S, Bescós-Atín C, Munill-Ferrer M, Alberola-Ferranti M. Impact of human papilloma virus in patients with oral and oropharyngeal squamous cell carcinomas. Med Clin (Barc). 2019;152(5):174-80. http://dx.doi.org/10.1016/j. medcli.2018.05.015. PMid:30777194.
21. Anantharaman D, Abedi-Ardekani B, Beachler DC, Gheit T, Olshan AF, Wisniewski K, Wunsch-Filho V, Toporcov TN, Tajara EH, Levi JE, Moyses RA, Boccia S, Cadoni G, Rindi G, Ahrens W, Merletti F, Conway DI, Wright S, Carreira C, Renard H, Chopard P, McKay-Chopin S, Scelo G, Tommasino M, Brennan P, D’Souza G. Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer. Int J Cancer. 2017;140(9):1968-75. http://dx.doi.org/10.1002/ ijc.30608. PMid:28108990.
22. Combes JD, Franceschi S. Role of human papillomavirus in non-oropharyngeal head and neck cancers. Oral Oncol. 2014;50(5):370-9. http://dx.doi.org/10.1016/j. oraloncology.2013.11.004. PMid:24331868.
23. Gillison ML, Alemany L, Snijders PJ, Chaturvedi A, Steinberg BM, Schwartz S, Castellsagué X. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine. 2012;30(Suppl 5):F34-54. http://dx.doi.org/10.1016/j.vaccine.2012.05.070. PMid:23199965.
24. You EL, Henry M, Zeitouni AG. Human papillomavirus-associated oropharyngeal cancer: review of current evidence and management. Curr Oncol. 2019;26(2):119-23. http://dx.doi.org/10.3747/co.26.4819. PMid:31043814.
25. Girardi FM. Prevalência da expressão de p16 no carcinoma epidermóide de orofaringe no sul do Brasil. Cirurgia Oral, Medicina Oral. Patologia Oral e Radiologia Oral. 2020;130(6):681-91. http://dx.doi.org/10.1016/j.oooo.2020.08.021.
26. Hong A, Lee CS, Jones D, Veillard AS, Zhang M, Zhang X, Smee R, Corry J, Porceddu S, Milross C, Elliott M, Clark J, Rose B. Rising prevalence of human papillomavirus-related oropharyngeal cancer in Australia over the last 2 decades. Head Neck. 2016;38(5):743-50. http://dx.doi.org/10.1002/hed.23942. PMid:25521312.
27. Habbous S, Chu KP, Lau H, Schorr M, Belayneh M, Ha MN, Murray S, O’Sullivan B, Huang SH, Snow S, Parliament M, Hao D, Cheung WY, Xu W, Liu G. Human papillomavirus in oropharyngeal câncer in Canada: analysis of 5 comprehensive cancer centres using multiple imputation. CMAJ. 2017;189(32):E1030-40. http://dx.doi.org/10.1503/cmaj.161379. PMid:28808115.
28. McDermott JD, Bowles DW. Epidemiology of head and neck squamous cell carcinomas: impact on staging and prevention strategies. Curr Treat Options Oncol. 2019;20(5):43. http://dx.doi.org/10.1007/s11864-019-0650-5. PMid:31011837.
29. Moro JS, Maroneze MC, Ardenghi TM, Barin LM, Danesi CC. Oral and oropharyngeal cancer: epidemiology and survival analysis. Einstein (Sao Paulo). 2018;16(2):1-5. http://dx.doi.org/10.1590/s1679-45082018ao4248.
30. Voltzke KJ, Lee Y-CA, Zhang Z-F, Zevallos JP, Yu G-P, Winn DM, Vaughan TL, Sturgis EM, Smith E, Schwartz SM, Schantz S, Muscat J, Morgenstern H, McClean M, Li G, Lazarus P, Kelsey K, Gillison M, Chen C, Boffetta P, Hashibe M, Olshan AF. Racial differences in the relationship between tobacco, alcohol, and the risk of head and neck cancer: pooled analysis of US studies in the INHANCE Consortium. Cancer Causes Control. 2018;29(7):619-30. http://dx.doi.org/10.1007/s10552-018-1026-z.
Submitted date:
04/02/2023
Accepted date:
07/02/2023
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email